ANTISENSE MODULATION OF SRC-2 EXPRESSION

Details for Australian Patent Application No. 2002245030 (hide)

Owner ISIS PHARMACEUTICALS, INC.

Inventors BENNETT, C., Frank; COWSERT, Lex, M.

Pub. Number AU-A-2002245030

PCT Pub. Number WO2002/057409

Priority 09/723,535 27.11.00 US

Filing date 26 November 2001

Wipo publication date 30 July 2002

Event Publications

13 February 2003 Application Open to Public Inspection

  Published as AU-A-2002245030

29 January 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002245031-COMPOSITIONS AND METHODS RELATING TO PROSTATE SPECIFIC GENES AND PROTEINS

2002245029-A COMBINATION AND METHOD OF TREATMENT OF CANCER UTILIZING A COX-2 INHIBITOR AND A 3-HYDROXY-3-METHYLGLUTARYL-C OENZYME-A (HMG-COA) REDUCTASE INHIBITOR